Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
16 pending office actions • 11 clients • 13 examiners • 8 art units • 0 of 16 (0%) have an AI response strategy ready
Veros Legal Solutions, LLP specializes in Medical Devices & Mechanical Engineering. The firm has managed 278 career applications and holds a resolved allowance rate pct of 75.95. This rate indicates the firm's success in securing allowances for its clients in the Medical Devices & Mechanical Engineering field. Practitioners can use the 278 career applications to evaluate the firm's historical outcomes. These metrics offer a basis for setting expectations for future filings in this technical area.
The firm has 11 pending office actions. Its avg office actions per allowance is 3.07. This 3.07 avg office actions per allowance reflects the number of examiner interactions typically required to reach an allowance. With 11 pending office actions, the firm continues to manage its active cases. The 3.07 avg office actions per allowance helps practitioners estimate the resources needed for the examination phase. The 75.95 resolved allowance rate pct and the 11 pending office actions provide a view of the firm's performance.
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (12%) |
| §102 only | 1 (6%) |
| §112 only | 1 (6%) |
| Multi-statute (no §101) | 12 (75%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GEIGER, RACHAEL L | 3 | 82.3% | +18.3% |
| ALLEN, ROBERT F | 2 | 73.2% | +61.9% |
| FISHBACK, ASHLEY LAUREN | 1 | 80.1% | +21.9% |
| HALL, FORREST G | 1 | 60.1% | +31.7% |
| GOMES, SRISTI DIVINA | 1 | 25.0% | -33.3% |
| MARCETICH, ADAM M | 1 | 72.7% | +18.8% |
| STRACHAN, KATE ELIZABETH | 1 | 48.2% | +29.2% |
| LEVY, BRANDON WILLIAM | 1 | 62.7% | +46.3% |
| MCEVOY, THOMAS M | 1 | 70.8% | +35.5% |
| GONZALEZ, LUISALBERTO | 1 | 59.4% | +47.2% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19572852 | INTRAVASCULAR FLOW DIVERTER AND RELATED METHODS | FISHBACK, ASHLEY LAUREN | — |
| 18958576 | VASCULAR ACCESS LINE AND IMPLANTATION DEVICES AND METHODS | GEIGER, RACHAEL L | — |
| 18918674 | VASCULAR ACCESS LINE AND IMPLANTATION DEVICES AND METHODS | GEIGER, RACHAEL L | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17146253 | MINIMALLY INVASIVE PORT IMPLANTATION | ALLEN, ROBERT F | 31d overdue |
| 18202051 | COMPOSITIONS FOR A DIETARY SUPPLEMENT TO MANAGE SENESCENT CELLS | GONZALEZ, LUISALBERTO | 13d |
| 18032030 | VASCULAR ACCESS KIT | MELHUS, BENJAMIN S | 53d |
| 18373829 | SYSTEM AND METHODS TO ENHANCE CHEMOTHERAPY DELIVERY AND REDUCE TOXICITY | LEVY, BRANDON WILLIAM | 61d |
| 19477303 | MONITORING SYSTEM FOR MEASURING VIBRATIONS | HALL, FORREST G | — |
| 19194548 | VASCULAR OCCLUSION COILS AND OCCLUDERS FORMED THEREWITH | GEIGER, RACHAEL L | — |
| 19100430 | VASCULAR ACCESS WIRE TIP COMPRISING A CRANK | GOMES, SRISTI DIVINA | — |
| 18827495 | DEVICES, SYSTEMS AND METHODS FOR THE BROAD-SPECTRUM REDUCTION OF PRO-INFLAMMATORY CYTOKINES IN BLOOD | MARCETICH, ADAM M | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17146253 | MINIMALLY INVASIVE PORT IMPLANTATION | ALLEN, ROBERT F | 31d overdue |
| 18202051 | COMPOSITIONS FOR A DIETARY SUPPLEMENT TO MANAGE SENESCENT CELLS | GONZALEZ, LUISALBERTO | 13d |
| 18373829 | SYSTEM AND METHODS TO ENHANCE CHEMOTHERAPY DELIVERY AND REDUCE TOXICITY | LEVY, BRANDON WILLIAM | 61d |
| 19572852 | INTRAVASCULAR FLOW DIVERTER AND RELATED METHODS | FISHBACK, ASHLEY LAUREN | — |
| 19477303 | MONITORING SYSTEM FOR MEASURING VIBRATIONS | HALL, FORREST G | — |
| 19194548 | VASCULAR OCCLUSION COILS AND OCCLUDERS FORMED THEREWITH | GEIGER, RACHAEL L | — |
| 18958576 | VASCULAR ACCESS LINE AND IMPLANTATION DEVICES AND METHODS | GEIGER, RACHAEL L | — |
| 18918674 | VASCULAR ACCESS LINE AND IMPLANTATION DEVICES AND METHODS | GEIGER, RACHAEL L | — |
| Client (Assignee) | Pending OAs |
|---|---|
| Venacore Inc. | 2 |
| Embrace Medical Ltd. | 2 |
| Tacc Inc. | 2 |
| Sigyn Therapeutics, Inc. | 2 |
| Portal Access, Inc. | 2 |
| NV MEDTECH, Inc. | 1 |
| Ms2Protect AB | 1 |
| Sigyn Therapeutics | 1 |
| Qualia Life Sciences LLC | 1 |
| Luna Health | 1 |
| Curtin University | 1 |
| Art Unit | Apps |
|---|---|
| 3771 | 4 |
| 3783 | 2 |
| 3732 | 1 |
| 3781 | 1 |
| 1624 | 1 |
| 3741 | 1 |
| 3791 | 1 |
| 1792 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19572852 | INTRAVASCULAR FLOW DIVERTER AND RELATED METHODS | NV Medtech, Inc. | FISHBACK, ASHLEY LAUREN | 3771 | §112 | Non-Final OA | — | Pending | Mar 19, 2026 |
| 19477303 | MONITORING SYSTEM FOR MEASURING VIBRATIONS | Ms2Protect AB | HALL, FORREST G | 3732 | §102§103 | Non-Final OA | — | Pending | Oct 21, 2025 |
| 19194548 | VASCULAR OCCLUSION COILS AND OCCLUDERS FORMED THEREWITH | Venacore Inc. | GEIGER, RACHAEL L | §102§103 | Non-Final OA | — | Pending | Apr 30, 2025 | |
| 19100430 | VASCULAR ACCESS WIRE TIP COMPRISING A CRANK | Embrace Medical Ltd. | GOMES, SRISTI DIVINA | §102§112 | Non-Final OA | — | Pending | Jan 31, 2025 | |
| 18958576 | VASCULAR ACCESS LINE AND IMPLANTATION DEVICES AND METHODS | Tacc Inc. | GEIGER, RACHAEL L | 3771 | §102 | Non-Final OA | — | Pending | Nov 25, 2024 |
| 18918674 | VASCULAR ACCESS LINE AND IMPLANTATION DEVICES AND METHODS | Tacc Inc. | GEIGER, RACHAEL L | 3771 | §103 | Final Rejection | — | Pending | Oct 17, 2024 |
| 18827495 | DEVICES, SYSTEMS AND METHODS FOR THE BROAD-SPECTRUM REDUCTION OF PRO-INFLAMMATORY CYTOKINES IN BLOOD | Sigyn Therapeutics, Inc. | MARCETICH, ADAM M | §103§112 | Non-Final OA | — | Pending | Sep 06, 2024 | |
| 18802722 | EXTRA-LUMEN ADSORPTION OF VIRAL PATHOGENS FROM BLOOD | Sigyn Therapeutics, Inc. | STRACHAN, KATE ELIZABETH | §102§103 | Non-Final OA | — | Pending | Aug 13, 2024 | |
| 18373829 | SYSTEM AND METHODS TO ENHANCE CHEMOTHERAPY DELIVERY AND REDUCE TOXICITY | Sigyn Therapeutics | LEVY, BRANDON WILLIAM | 3781 | §103§112 | Non-Final OA | 61d | Pending | Sep 27, 2023 |
| 18277506 | VASCULAR OCCLUDER WITH INWARDLY INSERTABLE SEGMENT | Venacore Inc. | MCEVOY, THOMAS M | 3771 | §103§112 | Final Rejection | — | Pending | Aug 16, 2023 |
| 18202051 | COMPOSITIONS FOR A DIETARY SUPPLEMENT TO MANAGE SENESCENT CELLS | Qualia Life Sciences LLC | GONZALEZ, LUISALBERTO | 1624 | §102§103§112 | Non-Final OA | 13d | Pending | May 25, 2023 |
| 18135417 | SYSTEMS, DEVICES AND RELATED METHODS OF CONTROLLING INSULIN MANAGEMENT FOR DELIVERING INSULIN DURING A FASTING PERIOD | Luna Health, Inc. | NGUYEN, ANDREW H | 3741 | §103 | Non-Final OA | — | Pending | Apr 17, 2023 |
| 18032030 | VASCULAR ACCESS KIT | Embrace Medical Ltd. | MELHUS, BENJAMIN S | 3791 | §102§103 | Non-Final OA | 53d | Pending | Apr 14, 2023 |
| 18014918 | SUBCUTANEOUS PORT FOR MINIMALLY INVASIVE IMPLANTATION | Portal Access, Inc. | ALLEN, ROBERT F | 3783 | §103§112 | Final Rejection | — | Pending | Jan 06, 2023 |
| 17922951 | MODIFIED LUPIN PROTEIN | Curtin University | KIM, BRYAN | 1792 | §103§112 | Final Rejection | — | Pending | Nov 02, 2022 |
| 17146253 | MINIMALLY INVASIVE PORT IMPLANTATION | Portal Access, Inc. | ALLEN, ROBERT F | 3783 | §103§112 | Final Rejection | 31d overdue | Pending | Jan 11, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial